Eosinophilic Dermatoses: Recognition and Management.
Biological Products
/ therapeutic use
Biomarkers
/ analysis
Dermatologic Agents
/ therapeutic use
Eosinophilia
/ diagnosis
Eosinophils
/ immunology
Humans
Immunohistochemistry
/ methods
Immunosuppressive Agents
/ therapeutic use
Phototherapy
/ methods
Skin
/ immunology
Skin Diseases
/ diagnosis
Treatment Outcome
Journal
American journal of clinical dermatology
ISSN: 1179-1888
Titre abrégé: Am J Clin Dermatol
Pays: New Zealand
ID NLM: 100895290
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
pubmed:
13
5
2020
medline:
18
5
2021
entrez:
13
5
2020
Statut:
ppublish
Résumé
Eosinophilic dermatoses encompass a broad spectrum of diseases of different etiologies hallmarked by eosinophilic infiltration of the skin and/or mucous membranes, with or without associated blood eosinophilia. The wide range of dermatological manifestations of this spectrum, including nodules and plaques, pustules, blisters, ulcers, and urticarial lesions, is reflected in a non-univocal classification system. We identified six groups of eosinophilic dermatoses based on the predominant anatomic level of involvement: (1) epidermal; (2) of the dermal-epidermal junction; (3) dermal; (4) of the hypodermis and muscle fascia; (5) of the pilosebaceous unit; and (6) vascular/perivascular. We review clinicopathologic features and management of diseases belonging to each group, particularly: (1) pemphigus herpetiformis and atopic dermatitis as prototypes of the epidermal group; (2) bullous pemphigoid as prototypic eosinophilic dermatosis of the dermal-epidermal junction; (3) eosinophilic cellulitis (Wells syndrome), hypereosinophilic syndromes, Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome, eosinophilic dermatosis of hematologic malignancy and chronic spontaneous urticaria as paradigmatic dermal eosinophilic dermatoses; (4) eosinophilic fasciitis as an eosinophilic dermatosis with predominant involvement of the hypodermis and muscle fascia; (5) eosinophilic pustular folliculitis as a model of the pilosebaceous unit involvement; and (6) granuloma faciale, angiolymphoid hyperplasia with eosinophilia, and eosinophilic granulomatosis with polyangiitis, belonging to the vascular/perivascular group.
Identifiants
pubmed: 32394361
doi: 10.1007/s40257-020-00520-4
pii: 10.1007/s40257-020-00520-4
doi:
Substances chimiques
Biological Products
0
Biomarkers
0
Dermatologic Agents
0
Immunosuppressive Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM